News and announcements from AURIN — partnerships, R&D milestones, and company updates as we build our regenerative materials platform.
AURIN has entered a co-development agreement with a cosmeceutical brand partner to advance purified PDRN ingredients for skincare. The collaboration pairs AURIN's ingredient standardization with the partner's formulation and market expertise, targeting high-functional regeneration and lifting concepts. Joint evaluation of the ingredient specification is now under way.
AURIN has begun preclinical evaluation of a new low-molecular-weight collagen peptide line (AUR-C2), assessing absorption, functionality, and safety. The work supports the line's progression toward cosmeceutical and inner-beauty applications, with characterization data guiding the next development stage.
AURIN's research and production base at Songdo BRC Smart Valley in Incheon is now fully operational. The center brings molecular design, characterization, and quality standardization together under one roof, enabling the company to diversify its collagen, gelatin, and PDRN pipeline.
※ The announcements above are representative items prepared for this site and may be updated as our business progresses. For press or partnership inquiries, please contact us.
Press & Partnership